Skip to main content
. 2021 Nov 12;49(11):03000605211055378. doi: 10.1177/03000605211055378

Figure 1.

Figure 1.

Comparison of serum GP73 concentration in the control group and participants with NAFL disease at different clinical stages. ★P < 0.05 vs. the control group; *P < 0.05 vs. the NAFL group. N = 46, 45 and 30 for the NASH, NAFL and control groups, respectively.

GP, Golgi protein; NAFL, non-alcoholic fatty liver; NASH, non-alcoholic steatohepatitis.